Icosa Europe opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Icosa Europe

Patent Number:
Title:
Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy
Applicant:
Opposition Date:
Oct 1, 2020
Patent Number:
Title:
Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria
Opposition Date:
Dec 13, 2019

Competitors of Icosa Europe

MD HEALTHCARE INC.

PLURISTEM LTD.

Want to track Icosa Europe?

Feel free to send us a message here and we will get back to you